Restricted Mean Survival Time for Analysis and Interpretation of Clinical Trials for Heart Failure Devices

被引：0
|
作者：
Perego, Carlotta [1 ]
Sbolli, Marco [1 ]
Specchia, Claudia [2 ]
Oriecuia, Chiara [2 ]
Peveri, Giulia [3 ]
Fiuzat, Mona [4 ]
O'Connor, Christopher [1 ]
Metra, Marco [2 ]
Wei, Lee-Jen [5 ]
Psotka, Mitchell [1 ]
机构：
[1] Inova Heart & Vasc Inst, Falls Church, VA USA
[2] Univ Brescia, Brescia, Italy
[3] Univ Milan, Milan, Italy
[4] Duke Univ, Durham, NC USA
[5] Harvard Univ, Boston, MA 02115 USA
来源：
JOURNAL OF CARDIAC FAILURE | 2020年 / 26卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
179
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [1] Restricted mean survival time analysis in heart failure clinical trials
    Perego, C.
    Sbolli, M.
    Specchia, C.
    Oriecuia, C.
    Peveri, G.
    Fiuzat, M.
    O'Connor, C. M.
    Metra, M.
    Wei, L. J.
    Psotka, M. A.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 1039 - 1039
  • [2] Utility of Restricted Mean Survival Time Analysis for Heart Failure Clinical Trial Evaluation and Interpretation
    Perego, Carlotta
    Sbolli, Marco
    Specchia, Claudia
    Fiuzat, Mona
    McCaw, Zachary R.
    Metra, Marco
    Oriecuia, Chiara
    Peveri, Giulia
    Wei, Lee-Jen
    O'Connor, Christopher M.
    Psotka, Mitchell A.
    [J]. JACC-HEART FAILURE, 2020, 8 (12) : 973 - 983
  • [3] Statistical Considerations for Sequential Analysis of the Restricted Mean Survival Time for Randomized Clinical Trials
    Lu, Ying
    Tian, Lu
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2021, 13 (02): : 210 - 218
  • [4] Designing clinical trials with (restricted) mean survival time endpoint: Practical considerations
    Eaton, Anne
    Therneau, Terry
    Le-Rademacher, Jennifer
    [J]. CLINICAL TRIALS, 2020, 17 (03) : 285 - 294
  • [5] Restricted Mean Survival Time for Survival Analysis: A Quick Guide for Clinical Researchers
    Han, Kyunghwa
    Jung, Inkyung
    [J]. KOREAN JOURNAL OF RADIOLOGY, 2022, 23 (05) : 495 - 499
  • [6] Scaling and interpreting treatment effects in clinical trials using restricted mean survival time
    Karrison, Theodore
    Hu, Chen
    Dignam, James
    [J]. CLINICAL TRIALS, 2024,
  • [7] On the Restricted Mean Survival Time Curve in Survival Analysis
    Zhao, Lihui
    Claggett, Brian
    Tian, Lu
    Uno, Hajime
    Pfeffer, Marc A.
    Solomon, Scott D.
    Trippa, Lorenzo
    Wei, L. J.
    [J]. BIOMETRICS, 2016, 72 (01) : 215 - 221
  • [8] Cancer Biology and Survival Analysis in Cancer Trials: Restricted Mean Survival Time Analysis versus Hazard Ratios
    A'Hern, R. P.
    [J]. CLINICAL ONCOLOGY, 2018, 30 (09) : E75 - E80
  • [9] Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
    Karrison, Theodore
    Kocherginsky, Masha
    [J]. CLINICAL TRIALS, 2018, 15 (02) : 178 - 188
  • [10] Restricted Mean Survival Time: An Obligatory End Point for Time-to-Event Analysis in Cancer Trials?
    A'Hern, Roger P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (28) : 3474 - +
12345